SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences informs about board meeting

03 Aug 2022 Evaluate

Zydus Lifesciences has informed that meeting of the Board of Directors of the Company will be held on Wednesday, August 10, 2022 to consider, apart from other agenda items, approval of unaudited financial results for the quarter ended on June 30, 2022. The trading window as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed till August 15, 2022 and shall open for trading on and from August 16, 2022 for all the Directors and Designated Persons.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

928.85 -7.50 (-0.80%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×